These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 11763483)
1. Results of treatment with tamsulosin in men with acute urinary retention. Kim HL; Kim JC; Benson DA; Bales GT; Gerber GS Tech Urol; 2001 Dec; 7(4):256-60. PubMed ID: 11763483 [TBL] [Abstract][Full Text] [Related]
2. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia. Lucas MG; Stephenson TP; Nargund V BJU Int; 2005 Feb; 95(3):354-7. PubMed ID: 15679793 [TBL] [Abstract][Full Text] [Related]
3. Prostate size influences the outcome after presenting with acute urinary retention. McNeill AS; Rizvi S; Byrne DJ BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia. Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705 [TBL] [Abstract][Full Text] [Related]
5. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia. Desgrandchamps F; De La Taille A; Doublet JD; BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763 [TBL] [Abstract][Full Text] [Related]
6. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey. Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial. Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630 [TBL] [Abstract][Full Text] [Related]
8. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study. McNeill SA; Hargreave TB; Roehrborn CG; Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868 [TBL] [Abstract][Full Text] [Related]
9. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention. Ghalayini IF; Al-Ghazo MA; Pickard RS BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128 [TBL] [Abstract][Full Text] [Related]
10. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB. Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961 [TBL] [Abstract][Full Text] [Related]
11. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study. Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425 [TBL] [Abstract][Full Text] [Related]
12. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals. Gerber GS; Jahoda A; Bales GT; Albala DM Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221 [TBL] [Abstract][Full Text] [Related]
13. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size. Roehrborn CG; Kaplan SA; Jones JS; Wang JT; Bavendam T; Guan Z Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022 [TBL] [Abstract][Full Text] [Related]
14. The Reten-World survey of the management of acute urinary retention: preliminary results. Emberton M; Fitzpatrick JM BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683 [TBL] [Abstract][Full Text] [Related]
15. Holmium laser prostatic resection for patients presenting with acute urinary retention. Anderson CB; Helfand BT; McVary KT BJU Int; 2008 Dec; 102(11):1623-8. PubMed ID: 18710443 [TBL] [Abstract][Full Text] [Related]
16. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction. Alan McNeill S Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678 [TBL] [Abstract][Full Text] [Related]
17. Intermittent catheterization time required after interstitial laser coagulation of the prostate. Nishizawa K; Kobayashi T; Mitsumori K; Watanabe J; Ogura K Urology; 2004 Jul; 64(1):79-83. PubMed ID: 15245940 [TBL] [Abstract][Full Text] [Related]
18. Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia. Ichioka K; Ohara H; Terada N; Matsui Y; Yoshimura K; Terai A; Arai Y Int J Urol; 2004 Oct; 11(10):870-5. PubMed ID: 15479292 [TBL] [Abstract][Full Text] [Related]
19. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children. Vanderbrink BA; Gitlin J; Toro S; Palmer LS J Urol; 2009 Feb; 181(2):817-22; discussion 822. PubMed ID: 19110267 [TBL] [Abstract][Full Text] [Related]